Search

everythinglearnresearchcommunity

for

Search:↓

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Treating cystoid macular oedema in uveitis is difficult and risky.

Latanoprost can effectively treat eyelash hair loss, with 45% of patients showing hair regrowth and no reported side effects.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Mesotherapy might help reduce fat in specific areas for those close to their ideal weight, but more research and care are needed to ensure safety.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

A rare genetic skin condition usually affecting males was found in a 9-year-old girl.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Finasteride effectively treats central serous chorioretinopathy.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Taking Propecia might lead to the development of cataracts.

ECM-inspired wound dressings can help heal chronic wounds by controlling macrophage activity.

The document explains how to do skin procedures, care after surgery, and when to use certain treatments.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Finasteride, often used for hair loss, can potentially cause cataracts.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.